论文信息 - Asymmetric dimethylarginine, an endogenous NO synthase inhibitor, in human breast milk. - 字舞流文

Asymmetric dimethylarginine, an endogenous NO synthase inhibitor, in human breast milk.

H. Tsukahara | H. Nagasaka

[1] H. Tsukahara,et al. Determination of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, in umbilical blood. , 2008, Metabolism: clinical and experimental.

[2] T. Ertl,et al. Plasma Asymmetric Dimethylarginine Concentration during the Perinatal Period , 2007, Neonatology.

[3] M. Wolzt,et al. Umbilical vein plasma concentrations of asymmetrical dimethylarginine are increased in male but not female neonates delivered preterm: a pilot study. , 2006, Early human development.

[4] P. Vallance,et al. The synthesis and metabolism of asymmetric dimethylarginine (ADMA) , 2006, European Journal of Clinical Pharmacology.

[5] H. Tsukahara,et al. Nitric oxide metabolites and adrenomedullin in human breast milk. , 2004, Early human development.

[6] F. Akçay,et al. Effect of breast-feeding on concentration of nitric oxide in breast milk , 2002, Annals of clinical biochemistry.